Articles related to SIDE EFFECTS

Rodent and non-human primate studies showed glucagon and GIP agonism alone produced weight loss comparable to GLP-1-containing triple agonists in a Bluewater Biosciences-funded program.

Eleven commonly prescribed medication classes have been associated with new or worsening depression symptoms, with risk varying by dose, duration, and patient population.

A network meta-analysis of 24 antipsychotics across 78,193 patients with schizophrenia identified clozapine, amisulpride, olanzapine, and risperidone as most effective, with small-to-medium efficacy differences and notable variation in tolerability profiles.

From the perspective of the psychiatrist, the best-case scenario is that antidepressant use is merely a marker for dental implant failure. The worst-case scenario is that antidepressant drugs, especially SSRIs, directly predispose to dental implant failure.

“The increased risk of NAION with Wegovy is due to the higher dosage of semaglutide…the difference between the two dosages and the rates of NAION may indicate a dose-dependent increase in risk.” – Benjamin Bert, MD

“Hair loss can be very debilitating. We should start thinking about more proactive strategies to mitigate risks.” — Yagiz Matthew Akiska, MD/MPH candidate, George Washington University